POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 106 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,675,000 | +73520.3% | 2,500,000 | 0.0% | 0.89% | -15.4% |
| Q2 2023 | $22,650 | +24.6% | 2,500,000 | 0.0% | 1.05% | +17.6% |
| Q1 2023 | $18,175 | -99.9% | 2,500,000 | 0.0% | 0.89% | -7.1% |
| Q4 2022 | $18,225,000 | -5.7% | 2,500,000 | 0.0% | 0.96% | -11.6% |
| Q3 2022 | $19,325,000 | +13.5% | 2,500,000 | 0.0% | 1.09% | +0.8% |
| Q2 2022 | $17,025,000 | -14.6% | 2,500,000 | 0.0% | 1.08% | +5.3% |
| Q1 2022 | $19,925,000 | +42.3% | 2,500,000 | 0.0% | 1.02% | +88.2% |
| Q4 2021 | $14,000,000 | -27.2% | 2,500,000 | 0.0% | 0.54% | -18.9% |
| Q3 2021 | $19,225,000 | – | 2,500,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
| GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
| RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
| JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
| BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
| Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
| Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
| Atom Investors LP | 60,103 | $479,000 | 0.22% |